Healthcare Industry News:  Cardinal Health 

Devices Diagnostics Personnel

 News Release - July 19, 2007

Healthcare Executive Frank Leo Appointed Director of MonoGen

CHICAGO, ILLINOIS--(Healthcare Sales & Marketing Network)--Jul 19, 2007 -- MonoGen, Inc. ("Corporation") (Toronto:MOG.TO ) today announced that Frank Leo has been appointed to its board of directors and that Mr. Laurence Hootnick has resigned as a director. As previously disclosed, Mr. Hootnick had informed the company that he would resign as a director before the end of August 2007.


Mr. Leo has 27 years of experience in various operational and senior management positions of healthcare companies. Mr. Leo is presently Chief Executive officer of Morton Grove Pharmaceuticals, Inc., a Greater Chicago-based specialty pharmaceuticals company. Prior to that Mr. Leo was a Group President with Cardinal Health.

Norman J. Pressman, MonoGen's Executive Chairman and Chief Scientific Officer, commented that "We are extremely fortunate to have Frank join our board of directors. Frank's wealth of knowledge and experience in growing and managing private and public healthcare companies at all levels of operations will contribute significantly to our growth as we enter into commercialization. Also, we would like to express our gratitude to Mr. Hootnick who has been a director of MonoGen for the past five years. Mr. Hootnick's insights and counsel were instrumental in keeping the management team focused on its goals."

Mr. Leo added, "I am pleased to join the MonoGen board of directors as I see the potential for MonoGen to become a major player with products that improve the practice of healthcare while providing economic benefits to customers. In addition, I look forward to contributing to their long term success."

With operational headquarters in the United States (Greater Chicago area), MonoGen is a medical device company developing an integrated suite of fully automated devices (the SAVANT LABORATORY SYSTEM(TM)) for anatomic and molecular pathology laboratories. The SAVANT LABORATORY SYSTEM(TM) is being designed to automate processes performed by clinical laboratories to reduce their costs, increase throughput, and improve the quality and consistency of results.

The common shares of the Corporation are listed for trading on the Toronto Stock Exchange under the trading symbol "MOG".

Forward-Looking Statements

This press release contains statements that are forward-looking in nature. Statements preceded by the words believe, expect, anticipate, plan, intend, continue, estimate, may, will, and similar expressions are forward-looking statements. Forward-looking statements are based on the Corporation's beliefs and assumptions based on information available at the time the assumption was made. Forward-looking statements relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, new services, market forces, commitments and technological developments, relating to the Corporation. By its nature, such forward-looking information is subject to various risks and uncertainties which could cause the Corporation's actual results and experience to differ materially from the anticipated results or other expectations expressed. Those risks and uncertainties include, but are not limited to MonoGen's ability to raise additional capital, MonoGen's ability to execute its business plan while obtaining and maintaining at all times its various regulatory approvals, the performance of its strategic partners including the performance of Cardinal Health in the commercialization of the Corporation's products in the marketplace and the competitive response from existing and potential competitors. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date it is expressed in this document, and the Corporation undertakes no obligation to update publicly or revise any forward looking information, whether as a result of new information, future events or otherwise.


Source: MonoGen

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.